As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Ideanomics, a filing with the SEC revealed that on Wednesday, Chief Executive Officer Alfred Poor bought 62,975 shares of IDEX, at a cost of $1.19 each, for a total investment of $75,000. Ideanomics is trading trading flat on the day Thursday.
And on Tuesday, VP of Finance and Controller Ryan Fischesser bought $29,553 worth of Caribou Biosciences, buying 7,387 shares at a cost of $4.00 each. Before this latest buy, Fischesser bought CRBU on 2 other occasions during the past year, for a total investment of $7,753 at an average of $2.69 per share. Caribou Biosciences is trading down about 7.1% on the day Thursday. Fischesser was up about 228.2% on the buy at the high point of today's trading session, with CRBU trading as high as $13.13 at last check today.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.